Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, December 5, 2017

Public edition |

Newswise Cancer Research Wire for 05-Dec-2017

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Head and Neck Cancer Researchers to Convene in Scottsdale for Multidisciplinary Care Symposium February 15-17

Researchers will present peer-reviewed abstracts on new combination therapies, targeted therapies, immunotherapy, advanced radiation and surgical techniques, new staging systems, treatment guidelines and supportive care.

– American Society for Radiation Oncology (ASTRO)

Combination Strategy Could Hold Promise for Ovarian Cancer

Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly...

– Johns Hopkins Medicine

Proceedings of the National Academy of Sciences.; OC130454/W81XWH-14-1-0385, 2CA183214, K99CA204592, P30CA006973

New Process Could Be Key to Understanding Complex Rearrangements in Genome

A team led by Tufts University biologists has successfully harnessed new technology to develop an approach that could allow for rapid and precise identification of the CGRs involved in disease, cancer and disorder development, which is critical for d...

– Tufts University

Genome Research, Dec-2017; P01GM105473; R35GM118020; R01GM60987

Register Now to Cover Cutting-Edge Hormone Research

Members of the media can now register to cover the latest advances in hormone health and science at ENDO 2018, the Endocrine Society’s 100th Annual Meeting & Expo. The meeting will be held March 17-20, in Chicago, Ill.

– Endocrine Society

ENDO 2018, Mar -2018

New Test Provides Accurate Measure of DNA Damage from Chemical Compounds

A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.

– Georgetown Lombardi Comprehensive Cancer Center


Embargo expired on 04-Dec-2017 at 15:00 ET

Study Suggests That Where Guidelines Disagree, Physicians’ Experiences With Their Patients, Family and Friends Shape Breast Cancer Screening Recommendations

Results of a national survey of more than 800 physicians suggest that their experiences with patients, family members and friends with breast cancer are linked with their recommendations for routine mammograms.

– Johns Hopkins Medicine

JAMA: Internal Medicine; R21CA194194-02

‘Safe’ Tanners Who Use Sprays and Lotions Less Likely to Get Tattoos and Piercings than Frequent Sunbathers and Tanning Bed Users

People who often sunbathe or use tanning beds are more likely to try risky weight-loss methods and have cosmetic surgery, as well as get tattoos and piercings. But while people who seldom tan also may try unsafe diets and cosmetic surgery, they rarel...

– Baylor University

From Medical Discovery to Food and Fine Arts, Italian-American Contributions Celebrated at Annual Foundation Conference

At this year’s 42nd annual NIAF Gala Weekend at the Washington Marriott Wardman Park Hotel in D.C., all aspects of Italian heritage were celebrated, including food, the fine arts, and scientific discovery. The weekend’s events included the medica...

– Sbarro Health Research Organization (SHRO)

Faith in Cancer Care Team Keeps New Mexico Woman at UAMS

TIna Farber arrived in Arkansas with one thing on her mind — meeting her two new grandbabies. Her son’s third child had arrived in April, and her daughter was expecting her third about one month later.

– University of Arkansas for Medical Sciences

John Theurer Cancer Center Researchers Share 46 Cutting Edge Studies at 2017 ASH Meeting

Researchers from the Hackensack Merdian Health John Theurer Cancer Center at Hackensack University Medical Center will present results from 46 cancer-related studies during the American Society of Hematology (ASH) 59th Annual Meeting, which will tak...

– Hackensack Meridian Health

Johns Hopkins Scientists Propose Efficiency ‘Rules’ for Enhancing Use of New Gene Editing Technology

Johns Hopkins scientists have developed a streamlined method and accompanying efficiency “rules” for introducing new DNA sequences into cells after using the gene-cutting tool known as CRISPR. The scientists say the method, which they based on te...

– Johns Hopkins Medicine

Proceedings of the National Academy of Sciences; R01HD37047, R01DC004553, F32GM117814

MD Anderson to Present Key Drug Study Findings for Multiple Blood Cancers at ASH Annual Meeting

Researchers at The University of Texas MD Anderson Cancer Center will present their latest findings involving drug treatments for blood cancers at the American Society of Hematology’s (ASH) Annual Meeting & Exposition Dec. 8-12 in Atlanta.

– University of Texas M. D. Anderson Cancer Center

ASH Annual Meeting

Gastrointestinal Cancer Expert Dr. Angela Alistar Wants Public to Be Aware of Pancreatic Cancer’s Warning Signs

Nationally renowned gastrointestinal (GI) cancer physician-scientist Angela Alistar, MD thinks it is critical that everyone learn how to recognize the warning signs of pancreatic cancer. Dr. Alistar is medical director of GI medical oncology at the C...

Expert Available

– Atlantic Health System

2-Drug Combination May Boost Immunotherapy Responses in Lung Cancer Patients

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs, used together, ac...

– Johns Hopkins Medicine

Cell; CA12113; CA006973; CA180950

Embargo expired on 30-Nov-2017 at 12:00 ET

Double-Edged Sword: Killing Cancer Cells can also Drive Tumor Growth

Cancer therapies including radiation and chemotherapy seek to treat the disease by killing tumor cells. Now a team including researchers at Beth Israel Deaconess Medical Center (BIDMC) have shown that the dead and dying cancer cells generated by chem...

– Beth Israel Deaconess Medical Center

Journal of Experimental Medicine; RO1 01CA170549-02; ROCA148633-01A4; GM095467

Vulnerability Identified for Subtypes of Glioblastoma

Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University of California San Diego Sc...

– University of California San Diego Health

Cancer Cell

Some Chemicals in Smoke May Be Even More Dangerous Than Previously Thought

Though most “low molecular weight polycyclic aromatic hydrocarbons” (LMW PAHs) have not been shown to cause cancer alone, the study shows that in common combinations, these chemicals can help to spark the disease.

– University of Colorado Cancer Center

Archives of Toxicology

Anti-Malaria Drug Increases Sensitivity of High-Risk Leukemic Cells to Targeted Therapy

St. Jude Children’s Research Hospital scientists report that combining the anti-malaria drug DHA with an emerging class of targeted agents may improve treatment of a high-risk acute lymphoblastic leukemia subtype

– St. Jude Children's Research Hospital

Clinical Cancer Research

Single-Molecule DNA Sequencing Advances Could Enable Faster, More Cost-Effective Genetic Screening

University of Colorado Boulder researchers are developing new techniques for faster, more cost-effective single-molecule DNA sequencing that could have transformative impacts on genetic screening.

– University of Colorado Boulder

ACS Nano; Journal of the American Chemical Society

“Swiss Army Knife” Nanovaccine Carries Multiple Weapons to Battle Tumors

Researchers at the National Institute of Biomedical Imaging and Bioengineering have developed a synergistic cancer nanovaccine packing DNA and RNA sequences that modulate the immune response, along with anti-tumor antigens, into one small nanoparticl...

– National Institute of Biomedical Imaging and Bioengineering

Nat Comm, Nov-2017

Researchers Trace Timeline of Tumor Evolution in Metastatic Breast Cancer Patients

A new study by researchers at Huntsman Cancer Institute (HCI) at the University of Utah observed how breast cancer tumors evolve over time and demonstrated how changes within tumors may contribute to the process by which cancers no longer respond to ...

– Huntsman Cancer Institute at the University of Utah

Nature Communications

UTSW Scientists Take Early Step to Personalized Breast Cancer Care

UT Southwestern Medical Center researchers have developed a method to map protein changes that occur in different subtypes of breast cancer cells in response to DNA damage from a new class of chemotherapy drugs.

– UT Southwestern Medical Center

Cell Reports

Unlocking the Genetics of Cancer

For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives.

– UC Davis Comprehensive Cancer Center

Policy and Public Affairs

Advocates Reveal Cancer Survivorship Challenges and Resources during National Comprehensive Cancer Network’s Patient Advocacy Summit

Cancer survivors and patient advocates joined clinicians, employers, policy makers, and pharmaceutical and biotech industry representatives to address survivorship in cancer care at NCCN Patient Advocacy Summit.

– National Comprehensive Cancer Network® (NCCN®)


Sanford Health Announces $1 Million Health and Science Award

Sanford Health is creating one of the world’s most lucrative awards to recognize innovations in health care.

– Sanford Health

Embargo expired on 04-Dec-2017 at 10:00 ET

OICR Launches Groundbreaking Cancer Therapeutics Innovation Pipeline to Drive Cutting-Edge Therapies to the Clinic

The Ontario Institute for Cancer Research (OICR) today announced the Cancer Therapeutics Innovation Pipeline (CTIP) initiative and the first 10 projects selected in CTIP’s inaugural round of funding. CTIP aims to support the local translation of On...

– Ontario Institute for Cancer Research

Albert Einstein College of Medicine and John Theurer Cancer Center Receive $6.4 Million NIH Grant to Identify Breast Cancer Biomarkers

Researchers at Albert Einstein College of Medicine, part of Montefiore, and Hackensack Meridian Health John Theurer Cancer Center at Hackensack University Medical Center have secured a five-year, $6.4 million grant from the National Institutes of Hea...

– Hackensack Meridian Health

Rutgers Cancer Institute Physician-Scientist Awarded $954K for Prostate Cancer Research

Isaac Yi Kim, MD, PhD, MBA, urologic oncology section chief at Rutgers Cancer Institute of New Jersey has been awarded a $954,000 Department of Defense grant to explore how neuroendocrine markers impact a common treatment for a type of prostate canc...

– Rutgers Cancer Institute of New Jersey


Two Former ASCB Presidents Win Breakthrough Prizes

Two past Presidents of the American Society for Cell Biology (ASCB), Don Cleveland and Peter Walter, are among the winners of the 2018 Breakthrough Prize in Life Sciences. Cleveland, a researcher at the University of California, San Diego, was 2013 A...

– American Society for Cell Biology (ASCB)

Embargo expired on 03-Dec-2017 at 19:30 ET

Ludwig Cancer Research Scientist Don Cleveland Wins Breakthrough Award

Ludwig Cancer Research extends its warmest congratulations to Don Cleveland, who has been a Member of the Ludwig Institute for Cancer Research since 1995 and today was awarded the prestigious Breakthrough Prize.

– Ludwig Cancer Research

D’Angelo Receives American Cancer Society Research Scholar Grant

Maximiliano D’Angelo, Ph.D., an assistant professor at Sanford Burnham Prebys Medical Discovery Institute (SBP), has received a four-year, $792,000 Research Scholar Grant from the American Cancer Society.

– Sanford Burnham Prebys Medical Discovery Institute

Embargo expired on 01-Dec-2017 at 09:00 ET

State’s Stem Cell Agency Awards Nearly $8 Million for New Leukemia Therapies

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researcher...

– University of California San Diego Health

Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Receives Rare Honor of Three-Year Accreditation With Commendation From the American College of Surgeons

The Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai has been honored with a three-year accreditation with commendation from the American College of Surgeons. Accreditation by the college’s quality assurance program, called the Commissi...

– Cedars-Sinai

New Prostate Biopsy Procedure Now Offered at Bayshore Medical Center

Hackensack Meridian Health Bayshore Medical Center is proud to announce that it has expanded services to include targeted MRI ultrasound for prostate biopsy. The procedure utilizes both ultrasound and magnetic resonance imaging (MRI) to allow for be...

– Hackensack Meridian Health

GW School of Medicine & Health Sciences Participates in Scientific Research Summit in Spain

The George Washington University School of Medicine and Health Sciences will participate in the First International Scientific Research Summit of the GW-Spain Consortium in Madrid on Dec. 1–2.

– George Washington University

With $6.6 Million Award From PCORI, UCLA Scientists to Study Effectiveness of Strategies Designed to Increase the Use of the HPV Vaccine to Prevent Cancer

UCLA researcher Dr. Roshan Bastani will lead a $6.6 million research study awarded by the Patient-Centered Outcomes Research Institute (PCORI) to investigate the comparative effectiveness of strategies designed to increase receipt of the human papill...

– University of California, Los Angeles (UCLA), Health Sciences


Perlmutter Cancer Center Expands Clinical Leukemia Program

NYU Langone Health has announced that nationally renowned physician and researcher Raoul Tibes, MD, PhD, will lead efforts to expand the clinical and investigative leukemia programs at its Perlmutter Cancer Center.

– NYU Langone Health

National Comprehensive Cancer Network Introduces New Guidelines for Patients with a Form of Cancer Associated with HIV and AIDS

Brand new NCCN Guidelines® map out best practices for treating patients with AIDS-related Kaposi sarcoma.

– National Comprehensive Cancer Network® (NCCN®)

Dr. J. William Charboneau Receives Lifetime Achievement Award

CHICAGO — For J. William Charboneau, M.D., life is a journey of unknown possibilities, filled with family. And Tuesday, Nov. 28, with family both personal and professional by his side and in the audience, Dr. Charboneau’s journey reached another ...

– Mayo Clinic

Expert Pitch

Lung Cancer Awareness Month: Expert Available to Discuss Curative Treatment for Early-Stage NSCLC

– American Society for Radiation Oncology (ASTRO)





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 UT Southwestern Medical Center

 University of California San Diego Health

 University of Texas M. D. Anderson Cancer Center

 George Washington University

 University of California, Los Angeles (UCLA), Health Sciences

 Ontario Institute for Cancer Research

Subscribe / Unsubscribe
Edit my preferences

© 2017 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us